← Back to headlines
Guardant Health Ordered to Pay $245 Million in DNA Sequencing Patent Lawsuit
A court has ruled that Guardant Health must pay $245 million to resolve a patent dispute over DNA sequencing technology, marking a significant legal victory for the opposing party.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Norway’s Digitalisation Agency Defends Against Ongoing Cyberattack
29m ago
Cyprus Advances Battery Storage Projects to Stabilize Renewable Grid
40m ago
Underage Social Media Use Rises in Australia Despite Legislative Ban
50m ago
Meta and US States Negotiate Settlement Over Teen Social Media Harm Lawsuits
54m ago